Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P777: Comparison of costs of different biologic therapies after dose optimisationECCO '18 Vienna
Year: 2018
Authors:

V. Borzan1,2, V. Orsic Fric1,2*, B. Borzan2

1Clinical Hospital Centre Osijek, Department of Gastroenterology and Hepatology, Osijek, Croatia, 2University J.J. Strossmayer of Osijek, Faculty of Medicine, Osijek, Croatia

P778: Real-world drug treatment costs for ulcerative colitis and Crohn’s disease patients treated with vedolizumab vs. anti-TNFα: Results from a German retrospective chart review studyECCO '18 Vienna
Year: 2018
Authors:

S. Campbell-Hill1*, D. Stein2, M. Soni2, C. Coombs3, B. Ratsch4, J.M. Khalid1, K. Minda5

1Takeda Development Centre Europe Ltd., Evidence and Value Generation, London, UK, 2Evidera, London, UK, 3Evidera, Bethesda, MD, USA, 4Takeda Pharma Vertrieb GmbH & Co. KG, Market Access and Public Affairs, Berlin, Germany, 5Takeda Pharmaceuticals International AG, Zurich, Switzerland

P779: Clinical outcome with biological therapy in ulcerative colitis: Real-world clinical setting from a multi-centre observational studyECCO '18 Vienna
Year: 2018
Authors:

L. Ramos1*, A. Hernandez Camba1, R. De La Barreda1, M. Vela2, I. Alonso-Abreu1, R. Gloria Esther2, M. Carrillo-Palau1, C. Tardillo2, Y. Rodríguez2, A. Figueroa Marrero3, D. Ceballos3, N. Cruz4, L. Kolle Casso5, A. Jiménez6, E. Quintero Carrión1,7

1Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain, 2Hospital Universitario Nuestra Señora de Candelaria, Gastroenterology, Santa Cruz de Tenerife, Spain, 3Hospital Universitario Dr. Negrín Gran Canaria, Gastroenterology, Las Palmas de Gran Canaria, Spain, 4Hospital José Molina Orosa Lanzarote, Gastroenterology, Arrecife, Spain, 5Hospital General de La Palma, Gastroenterology, Santa Cruz de La Palma, Spain, 6Hospital Universitario de Canarias, Research Unit, La Laguna, Spain, 7Universidad de La Laguna, La Laguna, Spain

P780: Interchangeability by a biosimilar of infliximab: What do patients think?ECCO '18 Vienna
Year: 2018
Authors:

M. Baudrant1*, A. Roche1, B. Allenet1, L. Grange2, L. Bouillet3, N. Mathieu4, B. Bonaz4

1CHU Grenoble Alpes, Pharmacy, Grenoble, France, 2CHU Grenoble Alpes, Rhumatologie, Grenoble, France, 3CHU Grenoble Alpes, Médecine Interne, Grenoble, France, 4CHU Grenoble Alpes, Hépatogastroentérologie, Grenoble, France

P781: Biological treatment and surgery in IBD patients stratified by age groupsECCO '18 Vienna
Year: 2018
Authors:

S. Svatun Lirhus1*, M. Ekmark2, B. Saeboe2, B. Moum3, H.O. Melberg4,5

1The University of Oslo, Department of Health Management and Health Economics, Oslo, Norway, 2Takeda Pharmaceuticals, Asker, Norway, 3Oslo University Hospital, Department of Gastroenterology, Oslo, Norway, 4Universitetet i Oslo, Department of Health Management and Health Economics, Oslo, Norway, 5Oslo University Hospital, OCBE, Oslo, Norway

P782: Natural history of acute severe ulcerative colitis in elderly: A population-based studyECCO '18 Vienna
Year: 2018
Authors:

L. Bril1*, A. Leroyer2, M. Fumery3, C. Charpentier1, B. Pariente2, H. Sarter2, D. Laharie4, C. Gower-rousseau2, G. Savoye1

1CHU Charles Nicolle, Gastroenterology, Rouen, France, 2CHU Lille, Gastroenterology, Lille, France, 3CHU Amiens, Gastroenterology, Amiens, France, 4CHU Bordeaux, Gastroenterology, Bordeaux, France

P783: Increased risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide population-based studyECCO '18 Vienna
Year: 2018
Authors:

E.A. Kang1*, J. Lee1, K. Han2, J. Kim1, J. Chun1, J.S. Kim1, J.P. Im1

1Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul, South Korea, 2College of Medicine, Catholic University of Korea, Department of Medical Statistics, Seoul, South Korea

P784: The direct healthcare costs of Crohn’s disease increased over the last two decades in a Dutch population-based cohortECCO '18 Vienna
Year: 2018
Authors:

R. Lalisang1*, D. Wintjens1,2, M. Romberg-Camps3, A. van Bodegraven3, L. Oostenbrug3, J. Haans1, A. Masclee1,2, D. Jonkers1,2, M. Pierik1,2

1Maastricht University Medical Centre +, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht, The Netherlands, 2Maastricht University Medical Centre +, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands, 3Zuyderland Medical Centre, Department of Gastroenterology and Hepatology, Sittard-Geleen/Heerlen, The Netherlands

P785: Designing the first pan-European paediatric IBD database to allow the study of incidence and prevalence of UC, CD, and their rare and severe complicationsECCO '18 Vienna
Year: 2018
Authors:

P. Kemos1*, M. Aardoom2, F. Ruemmele3, L. de Ridder2, N. Croft1, on behalf of the PIBD SETQuality consortium and PIBDnet

1Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, Paediatric Gastroenterology, London, UK, 2Erasmus MC, Sophia Children's Hospital, Paediatric Gastroenterology, Rotterdam, The Netherlands, 3Université Paris Descartes, Sorbonne Paris Cité, APHP, Hopital Necker Enfants Malades, Department of Paediatric Gastroenterology, Paris, France

P786: The use and escalation of treatments in patients with inflammatory bowel disease; a 10 years follow-up of a Danish population-based inception cohortECCO '18 Vienna
Year: 2018
Authors:

B. Lo1*, I. Vind1, F. Bendtsen1, M. Vester-Andersen1,2, J. Burisch1

1Copenhagen University Hospital Hvidovre, The Gastro Unit, Medical Division, Hvidovre, Denmark, 2Zealand University Hospital, Medical Department, Køge, Denmark

P787: Impact of inflammatory bowel disease on working life: A French nationwide surveyECCO '18 Vienna
Year: 2018
Authors:

F. Gonzalez1,2*, A. Buisson3, A. Olympie3, M.-H. Ravel3, C. Bienenfeld4, L. Peyrin-Biroulet5

1Hepato-Gastroenterology, Nimes, France, 2CHU St Eloi, Montpellier, France, 3AFA, Paris, France, 4IFOP, Paris, France, 5CHRU Brabois, Nancy, France

P788: Significant medical and surgical morbidity in perianal Crohn’s disease: Results from a population-based studyECCO '18 Vienna
Year: 2018
Authors:

W.Y. Mak1*, O.S. Mak2, C.K. Lee3, W. Tang3, W.K. Leung4, M.K.K. Li5, F.H. Lo6, M.T. Wong7, A.S.F. Sze1, C.M. Leung8, S.W.C. Tsang9, E.H.S. Shan10, K.H. Chan11, B.C. Lam12, A.J. Hui13, W.H. Chow14, S.C. Ng3

1Queen Elizabeth Hospital, Medicine, Hong Kong, Hong Kong, 2The Chinese University of Hong Kong, Surgery, Hong Kong, Hong Kong, 3The Chinese University of Hong Kong, Medicine and Therapeutics, Hong Kong, Hong Kong, 4The University of Hong Kong, Medicine, Hong Kong, Hong Kong, 5Tuen Mun Hospital, Medicine and Geriatrics, Hong Kong, Hong Kong, 6United Christian Hospital, Medicine and Geriatrics, Hong Kong, Hong Kong, 7Princess Margaret Hospital, Medicine and Geriatrics, Hong Kong, Hong Kong, 8Pamela Youde Nethersole Eastern Hospital, Medicine, Hong Kong, Hong Kong, 9Tseung Kwan O Hospital, Medicine, Hong Kong, Hong Kong, 10Caritas Medical Centre, Medicine and Geriatrics, Hong Kong, Hong Kong, 11North District Hospital, Medicine, Hong Kong, Hong Kong, 12Kwong Wah Hospital, Medicine and Geriatrics, Hong Kong, Hong Kong, 13Alice Ho Miu Ling Nethersole Hospital, Medicine, Hong Kong, Hong Kong, 14Yan Chai Hospital, Medicine, Hong Kong, Hong Kong

P789: Incidence and survival of gastrointestinal cancer in patients with inflammatory bowel disease: A nationwide population-based study in KoreaECCO '18 Vienna
Year: 2018
Authors:

H.J. Kim1, J.J. Park2*, H.S. Ahn1

1College of Medicine, Korea University, Preventive Medicine, Seoul, South Korea, 2Gangnam Severance Hospital, Yonsei University College of Medicine, Internal Medicine, Seoul, South Korea

P790: Assessing the cost-effectiveness of Epstein–Barr virus screening in young men initiating combination therapy with infliximab and azathioprine for Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

B. Fennimore1, M.E. Gerich1, E.L. Barnes2, A.K. Hans3, H.H. Herfarth2, F.I. Scott1,4*

1University of Colorado School of Medicine, Division of Gastroenterology and Hepatology, Aurora, USA, 2University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill, USA, 3University of Colorado School of Medicine, Department of Medicine, Aurora, USA, 4University of Pennsylvania, Center for Clinical Epidemiology and Biostatistics, Philadelphia, USA

P791: Peripheral spondyloarthritis, peripheral arthritis, and IBD-related peripheral arthritis in patients with long-term IBD: Results from 20 years of follow-up in the IBSEN studyECCO '18 Vienna
Year: 2018
Authors:

A. Ossum1,2*, Ø. Palm3, M. Cvancarova4, B. Moum1,2, M. Høivik1, The IBSEN Study Group1,5

1Oslo university hospital, Gastroenterology, Oslo, Norway, 2University of Oslo, Institute of Clinical Medicine, Oslo, Norway, 3Oslo university hospital, Department of Rheumatology, Oslo, Norway, 4Oslo and Akershus University College, Faculty of Health Sciences, Oslo, Norway, 5Diakonhjemmet Hospital, Gastroenterology, Oslo, Norway

P792: Prevalence of inflammatory bowel diseases in Israeli Jewish and Druze adolescents, a longitudinal comparative studyECCO '18 Vienna
Year: 2018
Authors:

S. Daher1*, L. Katz2,3, T. Khoury1, E. Lev4, A. Assa5, E. Israeli1

1Hadassah-Hebrew University Medical Center, Institute of Gastroenterology and Liver Diseases, Jerusalem, Israel, 2Sheba Medical Center, Department of Gastroenterology, Ramat Gan, Israel, 3Tel-Aviv University, Sackler School of Medicine, Tel Aviv, Israel, 4Hebrew University Hadassah Medical School, Jerusalem, Israel, 5Schneider Children's Hospital, Institute of Gastroenterology, Nutrition and Liver Diseases, Petach Tikva, Israel

P793: Prevalence and phenotype of inflammatory bowel disease across primary and secondary care: Implications for colorectal cancer surveillanceECCO '18 Vienna
Year: 2018
Authors:

N. Heerasing, P.J. Hendy, L. Moore, G.J. Walker, C. Bewshea, T. Ahmad, J. Goodhand, N.A. Kennedy*

University of Exeter, IBD Pharmacogenetics, Exeter, UK

P794: Vaccination and impact of vaccination for influenza among inflammatory bowel disease (IBD) patientsECCO '18 Vienna
Year: 2018
Authors:

C. Trivedi1, H. Kavani1, N. Khan1,2*

1Corporal Michael J. Crescenz, VA Medical Center, Gastroenterology, Philadelphia, USA, 2University of Pennsylvania, Perelman School of Medicine, Gastroenterology, Philadelphia, USA

P795: A specialised inflammatory bowel disease service provides equality of access to healthcare, irrespective of deprivation indicesECCO '18 Vienna
Year: 2018
Authors:

D. Sawbridge1, D. Storey1, B. Gregg1, C. Probert1,2, M. Burkitt1,2*

1Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK, 2The University of Liverpool, Cellular and Molecular Physiology, Liverpool, UK

P796: Adverse childhood events and psychiatric comorbidity in a single-centre IBD-cohortECCO '18 Vienna
Year: 2018
Authors:

A. Thomann1*, S. Lis2, W. Reindl1

1Medical faculty Mannheim, Heidelberg University, Department of medicine II, Mannheim, Germany, 2Central institute of mental health, Medical faculty Mannheim, Heidelberg University, Department of experimental psychology, Mannheim, Germany